annual_report
AFLAC
Loading viewer...
annual_report
Format: PDF annual_report
Alzamend Neuro, Inc. is a Delaware corporation formed in 2016 to develop and commercialize patented immunotherapy approaches for treating and preventing Alzheimer's disease. The company's novel therapeutic strategy differs from current FDA-approved Alzheimer's drugs by addressing the underlying immune system dysfunction rather than only treating symptoms.
annual_report
105 Pages
annual_report
80 Pages
ACADIA Pharmaceuticals
ADM 2013 Shareholder Letter Annual Results
annual_reportannual_report
4 Pages
Archer Daniels Midland Company
Alberta Health Services 2023 Annual Report
annual_reportannual_report
152 Pages
Alberta Health Services
annual_report
AFLAC
Archer Daniels Midland 2016 Annual Report and Stockholder Letter
annual_reportannual_report
196 Pages
Archer Daniels Midland Company